Healtcare Facilities company Rainbow Childrens Medicare announced Q1FY25 results: Revenue: Rs 3,302.2 million, up 15.0% YoY, down 3.2% QoQ. EBITDA: Rs 937.2 million, up 6.9% YoY, down 11.2% QoQ. EBITDA Margin: 28.4%, down 216 basis points YoY and 256 basis points QoQ. PAT: Rs 397.3 million, down 4.2% YoY, down 22.2% QoQ. PAT Margin: 12.0%, down 242 basis points YoY and 294 basis points QoQ. Commenting on the Performance for Q1 FY25, Ramesh Kancharla, Chairman & Managing Director of Rainbow Children’s Medicare, said: “I am delighted to share that we have delivered a strong performance this quarter. Our revenue for Q1 FY25 reached Rs 3,302 million, marking a robust 15% increase from Rs 2,872 million in Q1 FY24. Our EBITDA for the quarter was Rs 937 million, reflecting a growth of 6.9% compared to Rs 877 million in Q1 FY24. Although our PAT for Q1 FY25 was Rs 397 million, a decrease of 4.2% from Rs 415 million in Q1 FY24, this is attributable to the initial costs associated with our new hospitals. We currently have 2000+ beds including the managed beds, with a right mix of matured and new beds. Our focus remains to drive occupancies and optimize operations across the group along with custromer delight. We are confident in our ability to drive growth in the upcoming quarters.” Result PDF
Conference Call with Rainbow Childrens Medicare Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Rainbow Childrens Medicare announced Q4FY24 & FY24 results: Board recommends final dividend of 30% per Equity Share of Face Value Rs 10 amounting to Rs 304.5 million [Dividend Rs 3 per equity share] Project Status update: Development of the spoke hospital at Hennur, Bengaluru (~60 beds) and the regional spoke hospital at Rajahmundry (~100 beds) is progressing well and will be completed in the next 12 months. Both the hospitals are likely to commence operations in Q4FY25. For the regional spoke hospital at Coimbatore, the project work has just started and is expected to commence operations in 24 months. The company has received the possession letter for the land parcels at Gurugram at sector 44 and 56 respectively. The company expects the ground breaking in next 3-4 months. The company continued to have strong balance sheet and have cash & cash equivalent, fixed deposits and mutual fund investments aggregating to Rs 5,159 million as of March 31, 2024, which will be deployed for the ongoing capex plan of the company. Based on the present cash flow and expected internal accrual in the coming years, the company expects to complete all the planned capex with internal accruals and balance IPO funds. During the quarter, company has spent Rs 504 million for the capex. Commenting on the performance for Q4FY24 Dr. Ramesh Kancharla, Chairman & Managing Director, Rainbow Children’s Medicare said, “We had a significant quarter with three new hospitals commissioned in a span of three months. Our project and operations team have worked exceedingly well to ensure that all the projects were commissioned on time. With major expansion completed, we are solely focused on building and strengthening operations at newly commissioned hospitals and add services at existing units to propel them to new areas of growth” Result PDF
Healthcare Facilities company Rainbow Childrens Medicare announced Q3FY24 results: Financial Performance: Revenue: Rs 3,359.6 million, marking a YoY growth of 9.6% compared to Rs 3,064.0 million in Q3FY23. EBITDA: Achieved Rs 1,180.8 million with a 10.6% increase from Rs 1,067.6 million in the same quarter the previous year. EBITDA margin was at 35.1%. Profit After Tax (PAT): Grew by 7.4%, reaching Rs 625.7 million from Rs 582.4 million in Q3FY23, with PAT margin reporting a slight dip by 38 bps to 18.6%. Operational Highlights: Capacity and Beds: Expanded to 1,655 operational beds, a 6% increase from 1,555 beds in Q3FY23. Occupancy Rate: Experienced a decrease to 50.8%, a 630 bps drop from 57.1% in Q3FY23. Inpatient Discharges: Slightly increased to 22,888 from 22,665 YoY. Outpatient Consultations: Small growth to 3,17,146 consultations, up from 3,15,485 in the same quarter last year. Deliveries: Witnessed an uptick to 4,127 deliveries compared to 4,019 previously. Average Revenue Per Occupied Bed (ARPOB): Stood at Rs 55,768. Average Length of Stay (ALOS): Reduced slightly to 2.63 days from 2.77 days YoY. New Developments and Expansion: Commissioned the 8th hospital in Hyderabad with 60 beds. Ongoing projects include the finalization of hospitals in Anna Nagar, Chennai, and Sarjapur Road, Bangalore, expected to commence in Q4FY24. Continued development in Hennur, Bangalore, and Rajahmundry, with expected completion in the next 12-15 months. Acquired two land parcels in Gurgaon for future expansion. Commenting on the performance for Q3FY24, Dr. Ramesh Kancharla, Chairman & Managing Director, Rainbow Children’s Medicare, said, “ I'm delighted to announce that our company has showcased a resilient operating and financial performance this quarter. The revenue for Q3FY24 was Rs 3,359.6 million, which is a growth of 9.6% compared to Rs 3,064.0 million in Q3FY23. The EBIDTA for Q3FY24 was Rs 1,180.9 million, which is a growth of 10.6% compared to Rs 1,067.6 million in Q3FY23 and the PAT for Q3FY24 was Rs 625.7 million, which is a growth of 7.4% compared to Rs 582.4 million in Q3FY23. We have managed to fortify our operations and deliver stable performance despite the continued seasonal headwinds. Our operating performance reflects our commitment to delivering high-quality healthcare to our patients. We remain dedicated to the timely execution and initiation of our projects and add 280 beds during the current financial year. The company continues its unwavering dedication to its mission: to provide outstanding multi-disciplinary pediatric and perinatal care. We are constantly refining our services to serve our patients." Result PDF
Conference Call with Rainbow Childrens Medicare Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Rainbow Childrens Medicare Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.